TRDA · Company research
Entrada Therapeutics, Inc. Common Stock (TRDA): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 5.42 | $264,307,622.9 | 165027622.90 | 3.3750000000000000 | — | — | 294.3292014476614699 | 1.13237003783026506891 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.